Differences in the concentrations of small, anionic, antimicrobial peptides in bronchoalveolar lavage fluid and in respiratory epithelia of patients with and without cystic fibrosis

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 4256-4259

  Brogden, Kim A ^a   Ackermann, Mark R ^b   McCray Jr , Paul B ^c   Huttner, Kenneth M ^d  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM;

EID: 0032783033     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.4256-4259.1999     Document Type: Article

References (16)

1. Arima, H., H. R. Ibrahim, T. Kinoshita, and A. Kato. 1997. Bactericidal action of lysozymes attached with various sizes of hydrophobic peptides to the C-terminal using genetic modification. FEBS Lett. 415:114-118.
2. Bals, R., X. R. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has hroad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95:9541-9546.
3. Brogden, K. A., M. Ackermann, and K. M. Huttner. 1998. Detection of anionic antimicrobial peptides in ovine bronchoalveolar lavage fluid and respiratory epithelium. Infect. Immun. 66:5948-5954.
4. Brogden, K. A., M. Ackermann, and K. M. Huttner. 1997. Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial. Antimicrob. Agents Chemother. 41:1615-1617.
5. Brogden, K. A., A. J. De Lucca, J. Bland, and S. Elliott. 1996. Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica. Proc. Natl. Acad. Sci. USA 93:412-416.
6. Davis, P. B., M. Drumm, and M. W. Konstan. 1996 Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154:1229-1256.
7. Ellison, R T., III, D. Boose, and F. M. LaForce. 1985. Isolation of an antibacterial peptide from human lung lavage fluid. J. Infect. Dis. 151:1123-1129.
8. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
9. Hiemstra, P. S., R. J. Maassen, J. Stolk, R. Heinzel-Wieland, G. J. Steffens, and J. H. Dijkman. 1996. Antibacterial activity of antileukoprotease. Infect. Immun. 64:4520-4524.
10. Kaser, M. R., and G. G. Skouteris. 1997. Inhibition of bacterial growth by synthetic SP-B1-78 peptides. Peptides 18:1441-1444.
11. LaForce, F. M., and D. S. Boose. 1984. Effect of zinc and phosphate on an antibacterial peptide isolated from lung lavage. Infect. Immun. 45:692-696.
12. LaForce, F. M., and D. S. Boose. 1981. Sublethal damage of Escherichia coii by lung lavage. Am. Rev. Respir. Dis. 124:733-737.
13. McCray, P. B., Jr., and L. Bentley. 1997. Human airway epithelia express a β-defensin. Am. J. Respir. Cell Mol. Biol. 16:343-349.
14. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
15. Tomee, J. F. C., P. S. Hiemstra, R. Heinzel-Wieland, and H. F. Kauffman. 1997. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J. Infect. Dis. 176:740-747.
16. Tomita, M., M. Takase, H. Wakabayashi, and W. Bellamy. 1994 Antimicrobial peptides of lactoferrin. Adv. Exp. Med. Biol. 357:209-218.